Hylan G-F 20 was safe and effective in knee osteoarthritis and had a relatively low cost-utility ratio

Affiliations

Comment

Deborah Symmons. ACP J Club. 2003 Jan-Feb.

. 2003 Jan-Feb;138(1):20.

No abstract available

Comment on

A prospective, randomized, pragmatic, health outcomes trial evaluating the incorporation of hylan G-F 20 into the treatment paradigm for patients with knee osteoarthritis (Part 1 of 2): clinical results.
Raynauld JP, Torrance GW, Band PA, Goldsmith CH, Tugwell P, Walker V, Schultz M, Bellamy N; Canadian Knee OA Study Group. Raynauld JP, et al. Osteoarthritis Cartilage. 2002 Jul;10(7):506-17. doi: 10.1053/joca.2002.0798. Osteoarthritis Cartilage. 2002. PMID: 12127830 Clinical Trial.